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Abstract
Background: Increased understanding of the genetic diversity of HIV-1 is challenging but important in the development of
an effective vaccine. We aimed to describe the distribution of HIV-1 subtypes in northern Tanzania among women enrolled
in studies preparing for HIV-1 prevention trials (hospitality facility-worker cohorts), and among men and women in an open
cohort demographic surveillance system (Kisesa cohort).
Methods: The polymerase encompassing partial reverse transcriptase was sequenced and phylogenetic analysis performed
and subtype determined. Questionnaires documented demographic data. We examined factors associated with subtype
using multinomial logistic regression, adjusted for study, age, and sex.
Results: Among 140 individuals (125 women and 15 men), subtype A1 predominated (54, 39%), followed by C (46, 33%), D
(25, 18%) and unique recombinant forms (URFs) (15, 11%). There was weak evidence to suggest different subtype
frequencies by study (for example, 18% URFs in the Kisesa cohort versus 5–9% in the hospitality facility-worker cohorts;
adjusted relative-risk ratio (aRR) = 2.35 [95% CI 0.59,9.32]; global p = 0.09). Compared to men, women were less likely to have
subtype D versus A (aRR = 0.12 [95% CI 0.02,0.76]; global p = 0.05). There was a trend to suggest lower relative risk of
subtype D compared to A with older age (aRR = 0.44 [95% CI 0.23,0.85] per 10 years; global p = 0.05).
Conclusions: We observed multiple subtypes, confirming the complex genetic diversity of HIV-1 strains circulating in
northern Tanzania, and found some differences between cohorts and by age and sex. This has important implications for
vaccine design and development, providing opportunity to determine vaccine efficacy in diverse HIV-1 strains.
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Introduction
Human immunodeficiency virus type 1 (HIV-1) is characterised
by extensive genetic variability, as a consequence of high
replication and mutation rates and frequent recombination [1,2].
Based on phylogenetic analysis, HIV-1 strains have been divided
into four major phylogenetic groups: M, N, O and P. Group M,
the predominant circulating group responsible for the global HIV-
1 pandemic [3], is divided into nine subtypes (designated A-D, F-
H, and J-K) [2]. Some of the viral strains, such as subtypes A and
F, have been further sub-divided into sub-subtypes A1-A5, and
F1–F2, respectively [4]. In addition, different subtypes may
recombine to form circulating recombinant forms (CRFs), which
continue to be transmitted from one individual to another, or
unique recombinant forms (URFs) if there is no evidence of
transmission from the patient in which they arose to another.
Currently, at least 58 CRFs and numerous URFs have been
identified [5].
Most known HIV-1 groups and subtypes have been reported in
Africa; this region shows the greatest diversity of circulating HIV-1
viral strains [4]. Tanzania is among the countries in Africa severely
affected by the HIV epidemic, with an estimated prevalence of
HIV among the general adult population of 5.7% in 2007/2008
[6]. The distribution of HIV-1 subtypes in different regions of
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Tanzania gives an impression of a genetically more complex and
diverse epidemic than some of its neighbouring countries. During
the initial phase of the epidemic in Tanzania, HIV-1 subtypes A
and D predominated and were found in similar proportions [7].
Subtype C was subsequently introduced during the late 1980s-
early 1990s from neighbouring southern African countries [4,7].
Currently, subtypes A1 and C are the main circulating strains
among the general population [8–10] and in high-risk groups
[9,11]. This is in contrast to the epidemics in other East African
countries, which consist of mainly subtypes A1 and D [12–14].
Tanzania also reports the highest prevalence of recombinant forms
within the East African region [8,9].
Increased understanding of the genetic diversity of HIV-1 is
challenging but important in the development of an effective
vaccine [15], and may impact transmission, diagnosis, disease
progression, viral burden, response to treatment and emergence of
ART resistance [1,16]. Limited information is available on the
distribution of HIV-1 subtypes in Tanzania and no studies have
been conducted in Mwanza region of northern Tanzania. We
describe the distribution of HIV-1 subtypes and associated risk
factors in this region, where we developed local laboratory
capacity to conduct HIV-1 viral genotyping. We included a
general population cohort and two high-risk cohorts to compare
the distribution of HIV-1 subtypes among different populations
and geographical locations.
Methods
Ethics statement
The studies were approved by the Ethics Committees of the
Tanzania National Institute for Medical Research (NIMR),
Kilimanjaro Christian Medical Centre (KCMC) and London
School of Hygiene and Tropical Medicine. All participants
involved in this study gave written informed consent (all aged
$18 years). Study documents were stored in a secure location to
ensure participants’ confidentiality. Staff were trained on confi-
dentiality issues, research ethics and protection of human subjects.
Those testing HIV-positive were referred to care and treatment
centres.
Study populations
We analysed data from women participating in two prospective
cohort studies conducted in preparation for trials of candidate
microbicides and HIV-1 vaccines (hospitality facility-worker
cohorts), and among men and women from the general population
enrolled in the Kisesa open cohort for demographic health
surveillance (Kisesa cohort; Figure 1). We aimed to enrol 50
individuals from each of the three cohorts, and analysed one
sample per participant.
Study procedures for hospitality facility-worker cohorts
Participants in the cohorts were recruited between 2008–2010
from hotels, restaurants, bars, guesthouses, food-sellers at make-
shift facilities, and shops selling traditionally-brewed beer in the
towns of Geita, Kahama, and Shinyanga near Mwanza city
(microbicides-preparedness study) and Moshi town (vaccines-
preparedness study). During a screening visit, women underwent
a brief interview to collect limited information about demographic
characteristics, behavioural risk factors and other information to
determine their study eligibility, and a blood sample was collected
for HIV testing. Women were eligible if they were aged 18–44
years, willing to undergo HIV testing and receive results, and not
planning to move away from the recruitment site for the duration
of the study.
Women fulfilling the inclusion criteria were invited to come to
an enrolment visit within 4 weeks. HIV-negative women were
eligible for enrolment in both the microbicides-preparedness and
the vaccines-preparedness studies. In the vaccines-preparedness
study, HIV-positive women with CD4 cell count $350 cells/mm3
and who were ART-naı¨ve with no indication to start ART were
also enrolled. At enrolment, structured face-to-face interviews
were conducted to obtain information about socio-demographic
characteristics, employment, reproductive history, sexual behav-
iour and work mobility. All women enrolled in the study were
scheduled to return to the clinic after every three months for 12
Figure 1. Map of the study areas in northern Tanzania. Created using StatSilk (2013; StatPlanet: Interactive Data Visualization and Mapping
Software. http://www.statsilk.com).
doi:10.1371/journal.pone.0081848.g001
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Table 1. Participant characteristics by cohort.
Cohort Overall P-value (X2 test)
Female hospitality
facility-workers from
3 towns near Mwanza city
Female hospitality
facility-workers in
Moshi town
Kisesa open cohort
study
N 53 (100%) 42 (100%) 45 (100%) 140 (100%)
HIV INFECTION
HIV status [1] 0.03
Prevalent 39 (74%) 29 (69%) 41 (91%) 109 (78%)
Seroconverter 14 (26%) 13 (31%) 4 (9%) 31 (22%)
DEMOGRAPHICS
Sex [2]
Male 0 (0%) 0 (0%) 15 (33%) 15 (11%)
Female 53 (100%) 42 (100%) 30 (67%) 125 (89%)
Age, years 30 [25,36] 30 [26,37] 35 [27,43] 31 [26,38]
,25 13 (25%) 6 (14%) 5 (11%) 24 (17%) 0.2
25–29 12 (23%) 12 (29%) 9 (20%) 33 (24%)
30–34 14 (26%) 12 (29%) 8 (18%) 34 (24%)
35–39 5 (9%) 7 (17%) 9 (20%) 21 (15%)
$40 9 (17%) 5 (12%) 14 (31%) 28 (20%)
Education 0.03
#Incomplete primary 15 (28%) 6 (14%) 20 (44%) 41 (29%)
Complete primary 33 (62%) 33 (79%) 24 (53%) 90 (64%)
$Secondary 5 (9%) 3 (7%) 1 (2%) 9 (6%)
Main job ,0.001
Missing 0 0 1 1
Waitress 22 (42%) 22 (52%) 0 (0%) 44 (32%)
Other hospitality facility staff [3] 31 (58%) 20 (48%) 1 (2%) 52 (37%)
Farming 0 (0%) 0 (0%) 27 (61%) 27 (19%)
Other 0 (0%) 0 (0%) 11 (25%) 11 (8%)
No work 0 (0%) 0 (0%) 5 (11%) 5 (4%)
Ethnicity ,0.001
Sukuma 25 (47%) 1 (2%) 40 (89%) 66 (47%)
Chaga 8 (15%) 18 (43%) 0 (0%) 26 (19%)
Other 20 (38%) 23 (55%) 5 (11%) 48 (34%)
Religion 0.03
Missing 1 0 0 1
Christian 40 (77%) 33 (79%) 36 (80%) 109 (78%)
Muslim 12 (23%) 9 (21%) 5 (11%) 26 (19%)
Other 0 (0%) 0 (0%) 4 (9%) 4 (3%)
Marital status ,0.001
Missing 2 0 0 2
Married/cohabiting 13 (25%) 9 (21%) 32 (71%) 54 (39%)
Widowed/separated/ divorced 31 (61%) 22 (52%) 11 (24%) 64 (46%)
Single 7 (14%) 11 (26%) 2 (4%) 20 (14%)
SEXUAL BEHAVIOUR
Age at first sex, years 0.63
Missing 7 1 6 14
,16 13 (28%) 8 (20%) 10 (26%) 31 (25%)
$16 33 (72%) 33 (80%) 29 (75%) 95 (75%)
Number of lifetime sexual partners 9 8 12 29 0.07
Missing 20 (45%) 22 (65%) 25 (76%) 67 (60%)
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months. During each visit, similar interviews, clinical examinations
and blood and genital sample collection were performed as at
enrolment. Blood and genital samples were transported to either a
laboratory at NIMR in Mwanza city (microbicides-preparedness
cohort) or KCMC in Moshi (vaccines-preparedness cohort) for
further processing.
For this virological study, we aimed to recruit all HIV
seroconverters identified during the follow-up of the cohorts. In
order to reach the target sample size, we also aimed to recruit all
HIV-positive women enrolled in the vaccines-preparedness study,
and a random sample of HIV-positive women identified during
the screening process in the microbicides-preparedness study.
Study procedures for Kisesa cohort
The Kisesa cohort has been described previously [17] and will
be reviewed here briefly. Kisesa is located about 20 kms from
Mwanza city, along the main road connecting Mwanza with
major cities in Kenya. Demographic surveillance has been
conducted at approximately half-yearly intervals since 1994. In
addition, detailed sero-surveys are conducted approximately every
three years to collect blood for HIV-1 testing and sexual behaviour
data. Typically around 70% of all adults aged$15 years who were
invited participated in the sero-surveys [18]. A sero-survey was
conducted in 2010–2011 (sero 6), in which dry blood spots were
taken from 9,276 participants and tested for HIV in the NIMR
laboratory in Mwanza. Individuals who requested voluntary
counselling and testing (VCT) in order to know their HIV status
were given a separate rapid test by trained VCT counsellors, and a
plasma blood sample was taken for storage in NIMR laboratories.
For the purpose of this study, we randomly selected plasma
samples from individuals who were HIV-1 positive during the sero
6 sero-survey.
HIV-1 diagnosis
Testing for infections was performed according to standard
operating procedures in each of the NIMR and KCMC
laboratories. In the hospitality facility-worker cohorts, HIV rapid
testing was performed at screening in parallel using SD Bioline
HIV-1/2 3.0 (Standard Diagnostics, Inc., Korea) and Determine
HIV-1/2 (Alere Medical, Co., Ltd, Japan) tests. If the rapid tests
were positive or discordant, HIV infection was confirmed in the
respective laboratories using either third generation Murex HIV
1.2.O (Abbott UK, Dartford, Kent, England) and Vironostika
HIV Uniform II plus O (bioMe´rieux Bv, The Netherlands)
enzyme-linked immunosorbent assays (ELISAs; at NIMR labora-
tory for the microbicides-preparedness study), or only Vironostika
HIV Uniform II plus O ELISA (at KCMC laboratory for the
vaccines-preparedness study). In the microbicides-preparedness
study, samples discrepant or indeterminate on ELISA were tested
for P24 Antigen (Genetics Systems HIV-1 Ag EIA, Bio-rad
Laboratories, Marnes-La Coquette, France) and if positive were
classified as HIV-positive. Samples negative for P24 antigen were
tested by Western Blot (INNO-LIA, HIV I/II score, Innogenetics
NV, Gent, Belgium). At enrolment and follow-up visits, HIV
testing was done using ELISAs as per the screening algorithm. In
the vaccines-preparedness study, the HIV testing algorithm used at
screening was applied at enrolment and throughout the follow-up
period.
In the Kisesa cohort, HIV tests were run on the DBS samples
using two ELISAs in series (Vironostika HIV-Uniform II Plus O
(bioMe´rieux Bv, the Netherlands) and if positive then Enzygnost
Anti-HIV 1/2 Plus (Dade Behring Neward, DE, USA)); only those
with two positive results were considered HIV-positive.
Table 1. Cont.
Cohort Overall P-value (X2 test)
Female hospitality
facility-workers from
3 towns near Mwanza city
Female hospitality
facility-workers in
Moshi town
Kisesa open cohort
study
0–4 16 (36%) 10 (29%) 6 (18%) 32 (29%)
5–9 8 (18%) 2 (6%) 2 (6%) 12 (11%)
$10
Number of sexual partners in last 12
months
,0.001
Missing 5 2 0 7
0–1 20 (42%) 28 (70%) 39 (87%) 87 (65%)
2–10 28 (58%) 12 (30%) 6 (13%) 46 (35%)
LABORATORY RESULTS
HIV VL [4] 0.08
Undetectable 3 (6%) 0 (0%) 0 (0%) 3 (2%)
Detectable 50 (94%) 42 (100%) 45 (100%) 137 (98%)
HIV VL, log10 copies/ml [5] 4.3 [3.5,4.8] 4.1 [3.4,4.7] 5.2 [4.1,5.7] 4.5 [3.6,5.2] 0.001 [6]
Results are n (%) for categorical variables and median [interquartile range] for continuous variables. Percentages are of non-missing values.
[1] HIV seroconverters defined as those with #36 months between last negative and first positive test dates.
[2] P-value omitted since differences are by design.
[3]Including food preparation, mamalishe and bar work.
[4] Lower limit of detection was 300 copies/ml, except for the 10 subsequent seroconverters, where the lower limit of detection was 75 copies/ml.
[5] Imputed as half the lower limit of detection, for those with undetectable HIV VL.
[6] Comparing categories split by the overall median.
doi:10.1371/journal.pone.0081848.t001
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Sample collection, viral load measurement and
genotyping
Among those selected for this virological study, whole blood was
collected to isolate peripheral blood mononuclear cells (PBMC)
and aliquot plasma. Frozen plasma samples were shipped to
University of Montpellier (UoM), France, for viral load (VL)
determination and HIV-1 genotyping. Viral RNA was extracted
using the MagNa pure Compact Nucleic Acid Isolation Kit
(Roche Diagnostics). HIV VL was determined at UoM by RT-
PCR (Generic HIV viral Load, Biocentric) and at KCMC
Biotechnology Laboratory, Moshi, Tanzania by RT-PCR (Abbott
M2000) for 10 women who seroconverted after the shipment of
samples to UoM.
The reverse transcriptase (RT) gene encompassing part of the
polymerase (HXB2 positions 2530–3334) was amplified by nested
PCR using primers RT19: (59-GGA-CAT-AAA-GCT-ATA-
GGT-ACA-G-39) and RT20: (59-CTG-CCA-GTT-CTA-GCT-
CTG-CTT-C-39) or MJ3: (59-AGT-AGG-ACC-TAC-ACC-
TGT-CA-39) and MJ4: (59-CTG-TTA-GTG-CTT-TGG-TTC-
CTC-T-39) in the first round and A1: (59-TTG-GTT-GCA-CTT-
TAA-ATT-TTC-CCA-TTA-GTC-CTA-TT-39) and NE1: (59-
CCT-ACT-AAC-TTC-TGT-ATG-TCA-TTG-ACA-GTC-CAG-
CT-39) in the second-round reactions [19,20]. The PCR
products were purified with a QIAquick PCR purification kit
(Qiagen, Valencia, CA) and sequenced using the BigDyeH
Terminator v3.1 Cycle Sequencing Kits (Applied Biosystems,
Foster City, CA) on an 8-cappillary ABI Prism 3500 Genetic
Analyzer (Applied Biosystems). The sequencing primers were A2
(2545R2564): 59-ATT-TTC-CCA-TTA-GTC-CTA-TT-39 and
NE2 (3300r3319): (59- ATG-TCA-TTG-ACA-GTC-CAG-CT-
39) [19,20]. Sequencing products were purified using Centri-
SepTM spin columns (Princeton Separations, Inc New Jersey,
USA).
Genotyping assay quality control
To successfully implement the genotyping assay developed by
UoM at NIMR, we randomly selected from our archive 39
duplicate plasma samples, which were previously processed in
UoM. Genotyping was performed independently at NIMR and
data generated compared to data obtained from UoM. Sequences
were assembled and edited using Sequencher, version 4.10.1
(GeneCodes Corporation, Ann Arbor, MI) and aligned using
ClustalW in Bio-Edit Sequence Alignment Editor v7.0.9.0 [21],
yielding a percentage identity for NIMR versus UoM results. We
determined the proportion achieving at least 98% [22] identity,
and the proportion with matching subtypes.
Genetic analysis of cohort samples
The nucleotide sequence chromatogram files were assembled
and edited using Sequencher version 4.10.1 (GeneCodes Corpo-
ration, Ann Arbor, MI). Sequences were aligned with reference
pure subtype sequences of HIV-1 group M downloaded from Los
Alamos National library (LANL) HIV Sequence Database [5]
using ClustalW in Bio-Edit Sequence Alignment Editor v7.0.9.0
[21]. The REGA HIV-1 sub-typing tool [23] at the Stanford
database was used to assign subtypes [24]. Phylogenetic trees were
inferred in SeaView version 4.3.5 [25], using HKY85 model [26]
and Neighbor-joining method [27] with 1000 bootstrap replicate
values [28].
Statistical methods
Participant characteristics were summarised by cohort and the
following variables: HIV-1 seroconverter (defined as #36 months
between the last negative and first positive test dates), sex, age,
education, main job, ethnicity, religion, age at first sex, number of
partners in lifetime, and last 12 months and HIV VL. We
investigated the characteristics associated with HIV-1 subtype
using multinomial logistic regression (with outcome of subtype
categories), adjusted for study, age and sex. The variables were
added to the model one at a time, and we included those with
overall p,0.10 in a multivariable model, from which we removed
those no longer meeting the p,0.10 threshold. Finally, we
considered adding each of the omitted variables (retaining those
with p,0.10). Continuous variables were categorised or their
effects were assumed linear (see Table 1). Analyses were performed
using Stata (StataCorp. 2009. Stata Statistical Software: Release 11.
College Station, TX: StataCorp LP).
Sequence Data
Sequences from this study were deposited in GenBank under
the following accession numbers: KC831606–KC831741.
Results
Participant characteristics
We selected 162 participant samples for analysis of which 11
(7%) were PCR-negative, 10 (6%) failed sequencing or had poor
sequences, and 1 (1%) was dropped due to sample mix-up in the
quality control check, leaving 140 (86%) samples that were
included in the present study. Of these, 53 (38%), 42 (30%) and 45
(32%) were from the microbicides-preparedness study, the
vaccines-preparedness study, and the Kisesa cohort, respectively.
In Table 1, we present the characteristics by study cohort
among participants included in the final genotyping analysis.
Overall, 31 (22%) were identified as HIV-1 seroconverters, the
majority of whom by design were female hospitality facility-
workers, since Kisesa surveys only occur every 3 years. Among
seroconverters, the median time from the first positive test date to
blood collection was 2 (interquartile range [IQR]: 0, 9) months.
The majority of participants were female (89%). Female hospitality
facility-workers were younger than participants from the Kisesa
cohort (median 30 versus 35 years). Women from the hospitality
facility-worker cohorts predominantly worked as waitresses or in
similar roles (42% in the towns near Mwanza city and 52% in
Moshi town), compared to mainly farming in the Kisesa cohort
(61%). Hospitality facility-workers were less likely to be married or
Figure 2. Distribution of HIV-1 subtype by cohort. X2 test,
p = 0.16.
doi:10.1371/journal.pone.0081848.g002
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Figure 3. pol gene analysis tree. Results are presented for the 136 sequences which passed for phylogenetic analysis.
doi:10.1371/journal.pone.0081848.g003
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Table 2. Subtypes by participant characteristics.
Subtype Overall P [1]
A C D URF
N 54 (39%) 46 (33%) 25 (18%) 15 (11%) 140 (100%)
Study 0.16
Hospitality facility-workers from
towns near Mwanza city
19 (36%) 23 (43%) 6 (11%) 5 (9%) 53 (100%)
Hospitality facility-workers in
Moshi town
17 (40%) 13 (31%) 10 (24%) 2 (5%) 42 (100%)
Kisesa open cohort study 18 (40%) 10 (22%) 9 (20%) 8 (18%) 45 (100%)
HIV INFECTION
HIV status [2] 0.43
Prevalent 43 (39%) 33 (30%) 22 (20%) 11 (10%) 109 (100%)
Seroconverter 11 (35%) 13 (42%) 3 (10%) 4 (13%) 31 (100%)
DEMOGRAPHICS
Sex 0.12
Male 5 (33%) 3 (20%) 6 (40%) 1 (7%) 15 (100%)
Female 49 (39%) 43 (34%) 19 (15%) 14 (11%) 125 (100%)
Age, years 32 [27,40] 32 [26,39] 29 [26,33] 33 [25,36] 31 [26,38]
,25 8 (33%) 9 (38%) 5 (21%) 2 (8%) 24 (100%) 0.27
25–29 13 (39%) 7 (21%) 9 (27%) 4 (12%) 33 (100%)
30–34 11 (32%) 14 (41%) 6 (18%) 3 (9%) 34 (100%)
35–39 7 (33%) 5 (24%) 5 (24%) 4 (19%) 21 (100%)
$40 15 (54%) 11 (39%) 0 (0%) 2 (7%) 28 (100%)
Education 0.14
#Incomplete primary 20 (49%) 8 (20%) 7 (17%) 6 (15%) 41 (100%)
Complete primary 33 (37%) 32 (36%) 17 (19%) 8 (9%) 90 (100%)
$Secondary 1 (11%) 6 (67%) 1 (11%) 1 (11%) 9 (100%)
Main job 0.18
Missing 0 0 0 1 1
Waitress 18 (41%) 13 (30%) 10 (23%) 3 (7%) 44 (100%)
Other hospitality facility staff [3] 18 (35%) 24 (46%) 6 (12%) 4 (8%) 52 (100%)
Farming 12 (44%) 5 (19%) 7 (26%) 3 (11%) 27 (100%)
Other/no work 6 (38%) 4 (25%) 2 (13%) 4 (25%) 16 (100%)
Ethnicity 0.88
Sukuma 26 (39%) 23 (35%) 9 (14%) 8 (12%) 66 (100%)
Chaga 11 (42%) 7 (27%) 5 (19%) 3 (12%) 26 (100%)
Other 17 (35%) 16 (33%) 11 (23%) 4 (8%) 48 (100%)
Religion 0.06
Missing 0 0 1 0 1
Christian 37 (34%) 39 (36%) 20 (18%) 13 (12%) 109 (100%)
Muslim 16 (62%) 7 (27%) 2 (8%) 1 (4%) 26 (100%)
Other 1 (25%) 0 (0%) 2 (50%) 1 (25%) 4 (100%)
Marital status 0.78
Missing 0 2 0 0 2
Married/cohabiting 18 (33%) 19 (35%) 9 (17%) 8 (15%) 54 (100%)
Widowed/separated/ divorced 28 (44%) 20 (31%) 11 (17%) 5 (8%) 64 (100%)
Single 8 (40%) 5 (25%) 5 (25%) 2 (10%) 20 (100%)
SEXUAL BEHAVIOUR
Age at first sex, years 0.67
Missing 7 5 1 1 14
,16 14 (45%) 8 (26%) 5 (16%) 4 (13%) 31 (100%)
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cohabiting (25% in the towns near Mwanza city and 21% in
Moshi town), compared to the Kisesa cohort (71%).
Overall, 93% of participants had not progressed to secondary
level education, 47% were of Sukuma ethnicity and 78% were
Christian. Participants from the hospitality facilities in Moshi and
the Kisesa cohort had lower numbers of sexual partners over their
lifetime and in the last 12 months, compared to hospitality facility-
workers in towns near Mwanza city (p = 0.07 and ,0.001,
respectively). The median HIV VL was 4.3, 4.1 and 5.2 log10
copies/ml in the microbicides-preparedness study, vaccines-
preparedness study and Kisesa cohort, respectively.
HIV genotyping
Quality Control. From the list of samples already processed
in UoM, we randomly selected 39 for HIV genotyping at NIMR.
Of these, four samples were not sequenced at UoM (2 failed PCR,
2 failed sequencing) and one did not have a matching sample in
the NIMR archive. Of the remaining 34 samples, 32 samples were
successfully sequenced and analysed, with 27 (84%) samples
meeting the $98% identity threshold. We failed to determine the
subtype of one sequence generated at UoM due poor quality of
sequence. Of the remaining 31 sequences, 28 (90%) had
concordant HIV subtypes. The three discrepant sequences were
of subtypes D versus C/D, C versus C/H, and CRF10_CD versus
C, for NIMR versus UoM, respectively.
HIV-1 subtype classification and distribution. We suc-
cessfully generated sequences from 140 participants, out of which
126 (90%) samples were sequenced at UoM and the remaining 14
(10%) samples were sequenced at NIMR where we developed
local laboratory capacity to conduct genotyping. The latter
samples were from participants who seroconverted after shipment
of samples to UoM or had sample mix up at UoM necessitating
retesting of samples at NIMR. Of 140 participants, 54 (39%)
infections were subtype A, 46 (33%) subtype C, 25 (18%) subtype
D and 15 (11%) URFs (Figure 2). The latter included subtypes C/
D (n = 5), B/D (n = 2), D/B (n = 2), A/C (n = 1), A/D (n = 1), C/A
(n = 1), C/H (n = 1), D/A (n = 1) and D/C (n = 1). After exclusion
of 4 short sequences, 136 were passed for phylogenetic analysis
(Figure 3).
In Table 2, we show the distribution of HIV-1 subtypes by
participant characteristics. The proportions of participants infect-
ed with subtype A virus were similar across the three study
populations, while the proportion with subtype C was relatively
higher among hospitality facility-workers in towns near Mwanza
city (43%) compared to the other populations (31% among
hospitality facility-workers in Moshi town and 22% in the Kisesa
cohort). Participants in the Kisesa cohort were more likely to be
infected with URF viruses (18%) compared to hospitality facility-
workers in towns near Mwanza city (9%) and Moshi town (5%).
The proportion of participants infected with subtype D was lowest
among hospitality facility-workers in towns near Mwanza (11%).
The distribution of HIV-1 subtypes by demographic and
behavioural factors was not uniform. The crude data suggest that
participants who were aged $40, those who had incomplete
primary versus higher education, Muslims compared to other
religions, and those reporting $10 lifetime sexual partners had
relatively higher proportions of subtype A. We also examined a
number of factors which were collected among female hospitality
facility-workers only (data not shown), including duration of
working in the facilities, number of places lived in the past year,
number of times in the past year spent .1 week away from home,
problematic alcohol drinking and past year history of exchanging
money or gifts for sex. There was no evidence that the HIV-1
subtype distribution differed by these factors.
Table 2. Cont.
Subtype Overall P [1]
A C D URF
$16 33 (35%) 33 (35%) 19 (20%) 10 (11%) 95 (100%)
Number of lifetime sexual partners 0.41
Missing 10 14 3 2 29
0–4 24 (36%) 19 (28%) 13 (19%) 11 (16%) 67 (100%)
5–9 13 (41%) 10 (31%) 8 (25%) 1 (3%) 32 (100%)
$10 7 (58%) 3 (25%) 1 (8%) 1 (8%) 12 (100%)
Number of sexual partners in last
12 months
0.76
Missing 1 5 1 0 7
0–1 37 (43%) 27 (31%) 14 (16%) 9 (10%) 87 (100%)
2–10 16 (35%) 14 (30%) 10 (22%) 6 (13%) 46 (100%)
LABORATORY RESULTS
HIV VL, log10 copies/ml [4] 4.3 [3.5,4.9] 4.6 [3.4,5.3] 4.5 [3.7,5.4] 5.0 [3.8,5.6] 4.5 [3.6,5.2]
,Median 29 (41%) 22 (31%) 14 (20%) 6 (8%) 71 (100%) 0.73
$Median 25 (36%) 24 (35%) 11 (16%) 13 (9%) 69 (100%)
Results are n (%) for categorical variables and median [interquartile range] for continuous variables. Percentages are of non-missing values. URF = unique recombinant
form.
[1] P-value from X2 test.
[2] HIV seroconverters defined as those with #36 months between known last negative and first positive test dates.
[3] Including food preparation, mamalishe and bar work.
[4] Imputed as half the lower limit of detection (300 copies/ml, except for the 10 subsequent seroconverters, where the lower limit of detection was 75 copies/ml), for
those with undetectable HIV VL. Median is as shown in Table 1 (4.5 log10 copies/ml).
doi:10.1371/journal.pone.0081848.t002
HIV-1 Subtypes in Different Tanzanian Cohorts
PLOS ONE | www.plosone.org 8 December 2013 | Volume 8 | Issue 12 | e81848
Table 3. Study-, age- and sex-adjusted associations between subtype and participant characteristics.
Study-, age- and sex-adjusted relative risk ratio (95% CI), relative to subtype
A P [1]
Subtype C Subtype D URF
Study 0.09
Hospitality facility-workers from towns near Mwanza city 1 (reference) 1 (reference) 1 (reference)
Hospitality facility-workers in Moshi town 0.63 (0.25,1.62) 2.00 (0.58,6.83) 0.46 (0.08,2.67)
Kisesa open cohort study 0.47 (0.15,1.44) 0.92 (0.19,4.53) 2.35 (0.59,9.32)
HIV status [2] 0.26
Prevalent 1 (reference) 1 (reference) 1 (reference)
Seroconverter 1.38 (0.52,3.65) 0.39 (0.09,1.67) 1.81 (0.43,7.56)
Sex 0.05
Male 1 (reference) 1 (reference) 1 (reference)
Female 0.79 (0.14,4.55) 0.12 (0.02,0.76) 2.00 (0.18,21.9)
Age, per 10 years 0.86 (0.54,1.38) 0.44 (0.23,0.85) 0.67 (0.34,1.33) 0.05
Education 0.18
#primary 1 (reference) 1 (reference) 1 (reference)
$secondary 7.09 (0.79,63.9) 1.57 (0.09,27.9) 3.30 (0.17,62.7)
Job 0.57
Waitress/recreational-related [3] 1 (reference) 1 (reference) 1 (reference)
Farmer 0.90 (0.14,5.91) 1.41 (0.13,15.7) 0.40 (0.03,4.91)
Other 2.03 (0.73,5.65) 1.02 (0.24,4.34) 1.29 (0.22,7.61)
Ethnicity 0.22
Sukuma 1 (reference) 1 (reference) 1 (reference)
Non-Sukuma 0.68 (0.23,2.04) 3.03 (0.59,15.5) 2.20 (0.45,10.7)
Religion 0.21
Christian 1 (reference) 1 (reference) 1 (reference)
Non-Christian 0.38 (0.14,1.05) 0.45 (0.12,1.68) 0.40 (0.08,2.02)
Marital status 0.61
Married 1 (reference) 1 (reference) 1 (reference)
Widowed/separated/divorced 0.48 (0.18,1.29) 1.33 (0.35,5.08) 0.49 (0.12,2.02)
Single 0.36 (0.09,1.54) 0.89 (0.17,4.69) 0.67 (0.09,5.04)
Age at first sex, years 0.7
,16 1 (reference) 1 (reference) 1 (reference)
$16 1.81 (0.66,4.99) 1.51 (0.44,5.21) 1.23 (0.32,4.81)
Number of life partners [4] 0.22
0–4 1 (reference) 1 (reference) 1 (reference)
5–9 0.72 (0.24,2.11) 0.93 (0.28,3.07) 0.15 (0.02,1.34)
$10 0.31 (0.06,1.55) 0.16 (0.01,1.69) 0.21 (0.02,2.31)
Number of partners in last 12 months 0.59
0–1 1 (reference) 1 (reference) 1 (reference)
2–10 0.88 (0.33,2.35) 1.47 (0.45,4.77) 2.31 (0.51,10.4)
HIV VL, per log10 copies/ml [5] 1.29 (0.85,1.96) 1.16 (0.68,1.97) 1.35 (0.74,2.47) 0.59
[1] P-value from likelihood ratio test, relative to model with study, age and sex only.
[2] HIV seroconverters defined as those with #36 months between last negative and first positive test dates.
[3] Including food preparation, mamalishe and bar work.
[4] Only 33% of men reported the number of lifetime partners, so it was not possible to fit a model with both sex and number of lifetime partners, therefore the results
reported are study- and age-adjusted only (and compared to model with study and age only).
[5] Imputed as half the lower limit of detection (300 copies/ml, except the 10 subsequent seroconverters, where the lower limit of detection was 75 copies/ml), for
those with undetectable HIV VL.
doi:10.1371/journal.pone.0081848.t003
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Our final regression model included study population, age and
sex only, since none of the other covariates reached p,0.10 after
adjustment for these factors. As shown in Table 3, there was some
evidence to suggest independent associations with subtype by study
population, age and sex (p = 0.09, 0.05, and 0.05, respectively),
although the confidence intervals were generally wide. In
particular, comparing females versus males, there was a lower
relative risk of being infected with subtype D compared to subtype
A (adjusted relative-risk ratio (aRR) = 0.12, 95% CI 0.02, 0.76).
Furthermore, there were trends to suggest lower relative risk of
subtypes C, D and URF compared to subtype A with older age
(aRR = 0.86, 95% CI 0.54,1.38; aRR = 0.44, 95% CI 0.23,0.85;
and aRR = 0.67, 95% CI 0.34,1.33, per 10 years, respectively).
Discussion
This study describes the molecular epidemiology of HIV-1
among men and women in a peri-urban general population and
among women known to be at increased risk of HIV-1 infection in
northern Tanzania. We observed multiple HIV-1 subtypes in the
study populations, confirming the complex genetic diversity of
HIV-1 strains circulating in these areas.
Our results show that HIV-1 subtypes A (39%) and C (33%)
were the most prevalent, followed by subtype D (18%) and URF
(11%). This is consistent with previous studies conducted in
northern Tanzania [8,11,29]. To our knowledge, this is the first
study to investigate the molecular epidemiology of HIV-1 in the
towns near Mwanza city, the main Tanzanian urban centre on the
shores of Lake Victoria. To our knowledge, only one study has
previously described the distribution of HIV-1 subtypes around
Lake Victoria, and this was conducted in Bukoba town of Kagera
region [8]. Findings from the previous and present studies suggest
that HIV-1 subtypes A and C may be the most prevalent subtypes
in these regions around Lake Victoria.
We observed a substantial proportion of recombinant viruses
across the three cohorts, with the general population cohort in
Kisesa having the highest frequency. However, this was a relatively
lower frequency than previously reported [7]. This confirms that
re-infection (or superinfection) may occur among people infected
with HIV, leading to recombinants that are subsequently
transmitted [30]. The high genetic variability of the virus may
pose significant problems in the specificity and/or sensitivity of
serological and molecular diagnostic tests [31]. In Uganda, genetic
variability was shown to have an effect on response to ART [32]
and the development of HIV dementia among individuals with
advanced immunosuppression [32] and this has implications for
the treatment of HIV infection. Likewise, an effective anti-HIV-1
vaccine should elicit efficient cellular as well as humoral immune
responses and, in particular, broadly neutralising antibodies able
to target the largest number of HIV-1 genetic forms [1,15,16,33].
We found only weak evidence of a difference in subtype
distribution by cohort, with a suggestion of higher prevalence of
subtype C, and lower subtype D, in hospitality facility-workers
from towns near Mwanza city compared to hospitality facility-
workers in Moshi town and the Kisesa general population. Higher
prevalence of subtype C among hospitality facility-workers may be
because they are more likely to be exposed to sex partners from
areas where subtype C is highly prevalent. We observed that
females were less likely to be infected with subtype D, compared to
subtype A. Furthermore, we found trends towards higher relative
prevalence of subtype A with older age. This may be due to
subtype A, along with subtype D, being more predominant at
earlier stages of the epidemic, with subtype C increasing over time,
or may be related to better prognosis among those infected with
subtype A compared to subtype D [34,35]. While this is a small
study, these differences warrant further investigation.
In the present study, we genotyped samples from multiple
cohorts recruited in five towns in northern Tanzania, including
women known to be at increased risk of infection and men and
women from the general population. Thus, we were able to
compare our results across the study populations with different
socio-demographic and risk behaviour profiles. These strengths
should be considered in light of a number of limitations. Firstly,
many of the participants were enrolled as prevalent cases, and so
the time of infection was unknown and may have been many years
earlier. This is relevant both because subtype distributions may
change over time, and because data on some risk factors,
particularly sexual behaviour, may apply to periods after infection.
Secondly, we amplified only a partial region of polymerase gene
and this may lead to misclassification of HIV-1 recombinant
forms. However, sequencing this gene provides opportunity for
future studies to examine primary HIV drug resistance mutations
[36]. Thirdly, the sample size was small, and included only a
relatively small number of men and seroconverters; the latter
constrained our ability to examine trends in the distribution over
time.
In summary, we have described the molecular epidemiology of
HIV-1 in northern Tanzania across divergent populations, and
confirmed the complex genetic diversity of HIV-1 strains
circulating in the study areas. These results underscore the need
for appropriate HIV-1 vaccine development to address the
multifaceted HIV epidemic. As reported in previous studies,
HIV-1 subtypes A and C were the most prevalent viral strains. We
also observed a substantial proportion of recombinant viruses,
although somewhat lower than previously reported. We found
some differences in the distribution of HIV-1 subtypes between
cohorts, and by age and sex. This study provides the groundwork
for future HIV-1 vaccine research to be conducted in northern
Tanzania. The populations involved in this study provide
opportunity to assess the efficacy of candidate vaccines against
diverse HIV-1 strains.
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